Glycans in Drug Design
Glycans are elements of numerous bio-therapeutic mediators, ranging from natural products to molecules based on rational plan to recombinant glycoproteins. The glycan components of these agents can be important aspects of their biological activity and therapeutic efficacy. Biochemistry and Glycobiology includes a multidisciplinary study of carbohydrate-binding proteins (lectins), glycolipids and some selected other plant proteins that are skilful of connecting with endogenous or foreign (macro) molecules. The eminence of the research is on protein-carbohydrate interaction and their involvement in signalling procedures in plants or in plant protection. Based on the formed fundamental alertness new methods are being industrialised to shield crop plants against pests and diseases.
Related Conference of Glycans in Drug Design
Glycans in Drug Design Conference Speakers
Recommended Sessions
- Glycobiology
- Biochemistry
- Evolution of Glycan Diversity
- Genomics and Metabolomics
- Glycans in Diseases and Therapeutics
- Glycans in Drug Design
- Glycan’s
- Glycochemistry
- Glycoimmunology
- Glycoinformatics
- Glycolipids and Glycopeptides
- Glyconeurobiology
- Glycopathology
- Glycosience
- Proteoglycan and Sialic acid
- Recent Advances in Glycobiology
- Synthesis and Biological Role of Glycans
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- Biochemistry - Glycobiology 2025 (Germany)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene regulation and Cell Signalling - Structural Biology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Hybrid approaches in Structure prediction - Structural Biology 2025 (Germany)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular biology techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)